Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 Aug;64(4):349-355.
doi: 10.20945/2359-3997000000267. Epub 2020 Jul 24.

A retrospective study of reducing unnecessary thyroid biopsy for American College of Radiology Thyroid Imaging Reporting and Data Systems 4 assessment through applying shear wave elastography

Affiliations

A retrospective study of reducing unnecessary thyroid biopsy for American College of Radiology Thyroid Imaging Reporting and Data Systems 4 assessment through applying shear wave elastography

Jieli Luo et al. Arch Endocrinol Metab. 2020 Aug.

Abstract

Objective The purpose of the study is to quantitatively assess shear-wave elastography (SWE) value in American College of Radiology Thyroid Imaging Reporting and Data Systems (ACR TI-RADS) 4. Materials and methods One hundred and fifty-two ACR TI-RADS 4 thyroid nodules undergoing SWE were included in the study. The mean (EMean), minimum (EMin) and maximum (EMax) of SWE elasticity were measured. Results The areas under the receiver operating characteristic (ROC) curves for SWE EMean, EMin and EMax in detecting benign and malignant nodules were 0.95, 0.83 and 0.84, respectively. Cut-off value of EMean ≤ 23.30 kPa is able to downgrade the lesion category to ACR TI-RADS 3 and cut-off value of EMean ≥ 52.14 kPa is able to upgrade the lesion category to ACR TI-RADS 5. Conclusions The EMean of SWE will probably identify nodules that have a high potential for benignity in ACR TI-RADS 4. It may help identify and select benign nodules while reducing unnecessary biopsy of benign thyroid nodules.

PubMed Disclaimer

Conflict of interest statement

Disclosure: no potential conflict of interest relevant to this article was reported.

Figures

Figure 1
Figure 1. Schematic diagram of ACR TI-RADS was showing in the figure.
Figure 2
Figure 2. Two hundred and fifty-six ACR TI-RADS 4 lesions were evaluated in the initial analysis. One hundred and four lesions were excluded for some reasons as shown in figure. The remaining 152 lesions were used for the final analysis.
Figure 3
Figure 3. The SWE value of mean (EMean), min (EMin) and max (EMax) with areas under the receiver operative characteristic (ROC) curve of 0.95, 0.83 and 0.84, respectively.
Figure 4
Figure 4. According to composition (solid), echogenicity (very hypoechoic), shape (wider than tall), margin (smooth) and echogenic foci (none), this nodule was ACR TI-RADS 4 with 5 points. The EMean of SWE was 18.85 kPa which was able to downgrade the lesion category to ACR TI-RADS 3. The pathology of this nodule was nodular hyperplasia.

Comment in

References

    1. Cao J, Huang YQ, Jiao-Sun, Lan XB, Ge MH. Clinicopathological and prognostic significance of SHP2 and Hook1 expression in patients with thyroid carcinoma. Hum Pathol. 2018 ;81:105-12. - PubMed
    1. Janus D, Wojcik M, Taczanowska A, Soltysiak P, Wedrychowicz A, Roztoczynska D, et al. Follow-up of parenchymal changes in the thyroid gland with diffuse autoimmune thyroiditis in children prior to the development of papillary thyroid carcinoma. J Endocrinol Invest. 2019 ;42(3):261-70. - PMC - PubMed
    1. Murugan AK, Munirajan AK, Alzahrani AS. Long noncoding RNAs: emerging players in thyroid cancer pathogenesis. Endocr Relat Cancer. 2018 ;25(2):R59-82. - PubMed
    1. Na KJ, Choi H. Immune landscape of papillary thyroid cancer and immunotherapeutic implications. Endocr Relat Cancer. 2018 ;25(5):523-31. - PubMed
    1. Tori M, Shimo T. Long-term efficacy of lenvatinib for recurrent papillary thyroid carcinoma after multimodal treatment and management of complications: a case report. BMC Cancer. 2018 ;18(1):698. - PMC - PubMed

LinkOut - more resources